The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.
Wegmans Food Markets, Inc. Issues Allergy Alert on Undeclared Egg in Wegmans Easter Bread, 17 oz.
Wegmans Food Markets, Inc. has initiated a voluntary recall of all Wegmans Easter Bread (braided loaf) 17 oz., UPC 77890 32431 (all code dates) because it contains egg, which is not declared on the label. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume this product.
Hickory Farms Issues Allergy Alert on Chipotle Ranch Sauce Due to Undeclared Milk
Hickory Farms, Inc., the specialty food and holiday gift retailer today announced a voluntary recall of its Chipotle Ranch Sauce due to an undeclared allergen on its label. The Chipotle Ranch Sauce is formulated with buttermilk powder, a known allergen.
Whole Foods Market Southwest Region Recalls Mini Butter Croissants Due to Undeclared Egg
Whole Foods Market Southwest Region is recalling mini butter croissants because they contain eggs, an undeclared allergen. People who have an allergy or severe sensitivity to eggs run the risk of serious or life-threatening allergic reaction if they consume these products.
Hospira Announces Voluntary Nationwide Recall of One Lot of 1% Lidocaine HCI INjection, USP, Due To Visible Particulates
Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary recall of one lot of 1% Lidocaine HCI Injection, USP to the user level due to a confirmed customer report of orange and black particulate within the solution and embedded within the glass vial.
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter
(NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer. The administration of glass particulate, if present in an intravenous drug, poses a potential safety risk to patients.
Nature’s Universe Issues Voluntary Worldwide Recall of All Thinogenics Products Sold Prior to 02/06/2014 Due to the Presence of Undeclared Sibutramine
Nature’s Universe is voluntarily recalling all lots of old Thinogenics product (product sold prior to February 6, 2014, hereinafter the “Old Product”) to the user level after FDA analysis revealed that the Old Product contained undeclared sibutramine.
Hospira Announces Nationwide Voluntary Recall of Seven Lots of Propofol Injectable Emulsion, USP, Due to Visible Particulates
Hospira, Inc. (NYSE: HSP), announced today that on April 2, 2014, it informed customers of a nationwide recall of seven lots of Propofol Injectable Emulsion, USP, to the user level due to a glass defect located on the interior neck of the vial, which was identified during a retain sample inspection where the glass vial contained visible embedded metal particulate. Free-floating metal particulates were also identified in vials upon further analysis.
FDA approves Ragwitek for short ragweed pollen allergies
The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflammation), in adults 18 years through 65 years of age.
FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids
In a safety communication notice issued today, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.